FDAsafety guidance66% confidence
Human Drug Compounding
Source: FDA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Azurity Pharmaceuticals; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Compounded drugs can serve an important medical need for certain patients, they also present a risk to patients.
Supporting Context
- Therapeutic area
- Pharmaceuticals · Compounding
- Sub-indication
- General
Related signal: FDA Orders Azurity Pharmaceuticals to Halt Distribution of Unapproved Compounding Kits